David Greenspan decreased its stake in Alnylam Pharmaceuticals Inc (ALNY) by 16.11% based on its latest 2018Q1 regulatory filing with the SEC. Slate Path Capital Lp sold 72,000 shares as the company’s stock declined 18.72% with the market. The hedge fund run by David Greenspan held 375,000 shares of the health care company at the end of 2018Q1, valued at $44.66 million, down from 447,000 at the end of the previous reported quarter. Slate Path Capital Lp who had been investing in Alnylam Pharmaceuticals Inc for a number of months, seems to be less bullish one the $10.80 billion market cap company. The stock increased 0.37% or $0.4 during the last trading session, reaching $107.46. About 454,887 shares traded. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has risen 43.86% since June 15, 2017 and is uptrending. It has outperformed by 31.29% the S&P500. Some Historical ALNY News: 20/04/2018 – ALNYLAM – AS PER SETTLEMENT, DICERNA WILL BE RESTRICTED IN ITS DEVELOPMENT RELATING TO OLIGONUCLEOTIDE-BASED THERAPEUTICS FOR A DEFINED SET OF CO’S TARGETS; 24/04/2018 – Alnylam Pharmaceuticals: Patisiran Reduced Composite Rate of All-Cause Hospitalization and Mortality by About 50%, Relative to Placebo; 15/05/2018 – Alnylam Pharmaceuticals Names Colleen Reitan to Bd of Directors; 24/04/2018 – ALNYLAM PHARMACEUTICALS INC – PATISIRAN DEMONSTRATED IMPROVEMENT IN MULTIPLE QUALITY OF LIFE MEASURES, COMPARED TO PLACEBO; 24/04/2018 – Alnylam Reports New Clinical Results From tAPOLLO Phase 3 Study of Patisiran; 20/04/2018 – ADVISORY-Alert on Dicerna, Alnylam litigation settlement wrongly coded to American Lorain; 28/03/2018 – Alnylam and Collaborators to Present Clinical Study Results in Acute Hepatic Porphyrias (AHPs) at The 53rd International Liver Congress™ of the European Association for the Study of the Liver (EASL); 26/04/2018 – Alnylam to Webcast Conference Call Discussing First Quarter 2018 Financial Results; 30/03/2018 – Big deal – $ALNY -8.3% Don’t miss Watch out Alnylam/Ionis: Pfizer’s positive PhIII tafamidis data makes drug a new rival @BrittanyMeiling; 07/05/2018 – Medicines Co: Inclisiran Drove Sustained Lowering of Key Atherogenic Lipoproteins
Willingdon Wealth Management increased its stake in Prudential Finl Inc (PRU) by 53% based on its latest 2018Q1 regulatory filing with the SEC. Willingdon Wealth Management bought 4,667 shares as the company’s stock declined 9.17% with the market. The institutional investor held 13,473 shares of the finance company at the end of 2018Q1, valued at $1.40M, up from 8,806 at the end of the previous reported quarter. Willingdon Wealth Management who had been investing in Prudential Finl Inc for a number of months, seems to be bullish on the $41.18B market cap company. The stock decreased 0.71% or $0.7 during the last trading session, reaching $98.05. About 1.62 million shares traded. Prudential Financial, Inc. (NYSE:PRU) has declined 5.66% since June 15, 2017 and is downtrending. It has underperformed by 18.23% the S&P500. Some Historical PRU News: 30/04/2018 – Two Oklahoma youth honored for volunteerism at national award ceremony in Washington, D.C; 02/05/2018 – PRUDENTIAL FINANCIAL 1Q ADJ OPER EPS $3.08, EST. $2.98; 30/04/2018 – Two Nebraska youth honored for volunteerism at national award ceremony in Washington, D.C; 30/04/2018 – Two Maine youth honored for volunteerism at national award ceremony in Washington, D.C; 19/04/2018 – DJ Prudential Financial Inc, Inst Holders, 1Q 2018 (PRU); 30/04/2018 – Two Delaware youth honored for volunteerism at national award ceremony in Washington, D.C; 27/03/2018 – A.M. Best Assigns Issue Credit Ratings to Prudential Financial Inc.’s New Senior Unsecured Notes; 30/04/2018 – Two South Dakota youth honored for volunteerism at national award ceremony in Washington, D.C; 30/04/2018 – Two Colorado youth honored for volunteerism at national award ceremony in Washington, D.C; 14/03/2018 – Prudential Global Short Duration High Yield Fund, Inc. Reports Unaudited Earnings and Financial Position for Quarter Ended January 31, 2018
Among 16 analysts covering Prudential Financial (NYSE:PRU), 12 have Buy rating, 0 Sell and 4 Hold. Therefore 75% are positive. Prudential Financial had 57 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Friday, May 5 by Wells Fargo. Credit Suisse maintained the stock with “Hold” rating in Friday, April 28 report. The rating was maintained by Wells Fargo on Tuesday, June 6 with “Hold”. Wells Fargo maintained Prudential Financial, Inc. (NYSE:PRU) on Friday, February 9 with “Market Perform” rating. UBS upgraded Prudential Financial, Inc. (NYSE:PRU) on Friday, March 2 to “Buy” rating. RBC Capital Markets maintained it with “Hold” rating and $11300 target in Monday, July 31 report. Bank of America downgraded the stock to “Underperform” rating in Wednesday, June 29 report. The company was maintained on Thursday, November 12 by Keefe Bruyette & Woods. On Thursday, December 21 the stock rating was maintained by Keefe Bruyette & Woods with “Buy”. On Friday, February 10 the stock rating was downgraded by Atlantic Securities to “Neutral”.
Willingdon Wealth Management, which manages about $239.04 million and $316.40 million US Long portfolio, decreased its stake in Exxon Mobil Corp (NYSE:XOM) by 7,836 shares to 62,617 shares, valued at $4.67 million in 2018Q1, according to the filing. It also reduced its holding in Dominion Energy Inc (NYSE:D) by 8,468 shares in the quarter, leaving it with 28,023 shares, and cut its stake in Murphy Usa Inc (NYSE:MUSA).
More recent Prudential Financial, Inc. (NYSE:PRU) news were published by: Bizjournals.com which released: “Prudential grabs $250 million stake in CityView’s 700-unit Bay Area apartment portfolio” on June 12, 2018. Also Bizjournals.com published the news titled: “Alamo Drafthouse sets opening date for new Houston-area theater, to close existing location” on June 15, 2018. Benzinga.com‘s news article titled: “Goldman’s Insurance Pair Trade: Prudential Financial Upgraded, Metlife Downgraded” with publication date: June 04, 2018 was also an interesting one.
Investors sentiment decreased to 1.16 in Q1 2018. Its down 0.02, from 1.18 in 2017Q4. It fall, as 44 investors sold PRU shares while 270 reduced holdings. 99 funds opened positions while 265 raised stakes. 259.90 million shares or 2.95% less from 267.81 million shares in 2017Q4 were reported. Coastline Tru has invested 0.07% in Prudential Financial, Inc. (NYSE:PRU). Community Fincl Bank Na reported 1,161 shares. Hanson And Doremus Invest owns 100 shares. Engineers Gate Manager Ltd Partnership owns 8,446 shares. Spc Inc holds 0.06% or 2,504 shares. Goelzer Invest Inc has invested 1.02% in Prudential Financial, Inc. (NYSE:PRU). Fred Alger Mgmt Inc invested in 165 shares or 0% of the stock. Moreover, Qs Investors Limited Liability Corporation has 0.01% invested in Prudential Financial, Inc. (NYSE:PRU) for 8,768 shares. Bnp Paribas Asset Mgmt Sa stated it has 165,365 shares or 0.14% of all its holdings. Nbt National Bank N A Ny invested 0.55% of its portfolio in Prudential Financial, Inc. (NYSE:PRU). Susquehanna Grp Inc Llp holds 0% or 3,323 shares in its portfolio. Putnam Ltd Liability Com accumulated 366,400 shares or 0.09% of the stock. Oarsman Cap Inc accumulated 25,929 shares. Spirit Of America Management reported 4,500 shares. Texas-based King Luther Capital Mgmt has invested 0.22% in Prudential Financial, Inc. (NYSE:PRU).
Since February 20, 2018, it had 0 buys, and 1 sale for $4.43 million activity.
Since January 4, 2018, it had 0 insider purchases, and 11 insider sales for $39.55 million activity. $5.50M worth of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) was sold by Greene Barry E. SCHIMMEL PAUL sold $4.17 million worth of stock or 27,823 shares. 88,554 shares were sold by Vaishnaw Akshay, worth $12.67 million on Wednesday, March 14. On Monday, March 26 Greenstreet Yvonne sold $985,958 worth of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) or 7,221 shares. SHARP PHILIP A sold $1.94M worth of stock or 15,000 shares. Ausiello Dennis A also sold $2.57M worth of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on Tuesday, March 13.
Analysts await Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) to report earnings on August, 8. They expect $-1.71 earnings per share, down 27.61% or $0.37 from last year’s $-1.34 per share. After $-1.41 actual earnings per share reported by Alnylam Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 21.28% negative EPS growth.
Slate Path Capital Lp, which manages about $4.31B and $1.56 billion US Long portfolio, upped its stake in Hertz Global Hldgs Inc by 285,000 shares to 715,000 shares, valued at $14.19 million in 2018Q1, according to the filing. It also increased its holding in Diamondback Energy Inc (NASDAQ:FANG) by 40,000 shares in the quarter, for a total of 255,000 shares, and has risen its stake in Dexcom Inc (NASDAQ:DXCM).
More notable recent Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) news were published by: Businesswire.com which released: “Alnylam to Report New Clinical Results for Patisiran at the 4” on June 15, 2018, also Seekingalpha.com with their article: “Alnylam’s lumasiran shows positive effect in Phase 1/2 PH1 study” published on June 08, 2018, Seekingalpha.com published: “Eidos Therapeutics files for initial public offering” on May 25, 2018. More interesting news about Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) were released by: Nasdaq.com and their article: “Better Buy: Bellicum Pharmaceuticals, Inc. vs. Alnylam Pharmaceuticals, Inc.” published on June 03, 2018 as well as Seekingalpha.com‘s news article titled: “Alnylam Pharmaceuticals Continues To Develop Options Outside Of Amyloidosis” with publication date: June 12, 2018.
Investors sentiment decreased to 1.4 in 2018 Q1. Its down 0.63, from 2.03 in 2017Q4. It is negative, as 25 investors sold ALNY shares while 67 reduced holdings. 43 funds opened positions while 86 raised stakes. 89.26 million shares or 1.02% less from 90.18 million shares in 2017Q4 were reported. Gulf Savings Bank (Uk) Limited accumulated 29,147 shares. Price T Rowe Assoc Inc Md reported 0.24% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Alkeon Cap Limited owns 4,540 shares. Sg Americas Lc owns 0.02% invested in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) for 22,886 shares. Riverhead Limited Liability owns 800 shares or 0% of their US portfolio. Brighton Jones Limited Company reported 4,004 shares. Driehaus Cap Management Ltd Liability Corp reported 5,348 shares. Two Sigma Securities Ltd owns 0% invested in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) for 2,524 shares. University Of Notre Dame Du Lac accumulated 22,130 shares or 0.49% of the stock. Emory University reported 21,316 shares or 1.81% of all its holdings. Amundi Pioneer Asset Mgmt owns 102,902 shares for 0.02% of their portfolio. Prudential Fincl Inc holds 0% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) or 4,744 shares. Moreover, Jpmorgan Chase has 0% invested in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) for 55,801 shares. Susquehanna Grp Ltd Liability Partnership reported 0% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). 2,666 were accumulated by Boothbay Fund Ltd Liability.